Digenic parkinsonism: Investigation of the synergistic effects of PRKN and LRRK2

This publication has 20 references indexed in Scilit:

• Clinical Features of Parkinson Disease Patients With Homozygous Leucine-Rich Repeat Kinase 2 G2019S Mutations
  Archives of Neurology, 2006
• Genetics of Parkinson disease: paradigm shifts and future prospects
  Nature Reviews Genetics, 2006
• LRRK2G2019S as a Cause of Parkinson's Disease in North African Arabs
  New England Journal of Medicine, 2006
• The Parkinson disease causing LRRK2 mutation I2020T is associated with increased kinase activity
  Human Molecular Genetics, 2005
• The G6055A (G2019S) mutation in LRRK2 is frequent in both early and late onset Parkinson's disease and originates from a common ancestor
  Journal of Medical Genetics, 2005
• Identification of a Novel LRRK2 Mutation Linked to Autosomal Dominant Parkinsonism: Evidence of a Common Founder across European Populations
  American Journal of Human Genetics, 2005
• The p38 subunit of the aminoacyl-tRNA synthetase complex is a Parkin substrate: linking protein biosynthesis and neurodegeneration
  Human Molecular Genetics, 2003
• Initiation and Synergistic Fibrillization of Tau and Alpha-Synuclein
  Science, 2003
• Heterozygosity for a mutation in the parkin gene leads to later onset Parkinson disease
  Neurology, 2003
• Diagnostic Criteria for Parkinson Disease
  Archives of Neurology, 1999